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Summary
Macrophage activation is characterized by pronounced metabolic adapta-
tion. Classically activated macrophages show decreased rates of mitochon-
drial fatty acid oxidation and oxidative phosphorylation and acquire a
glycolytic state together with their pro-inflammatory phenotype. In con-
trast, alternatively activated macrophages require oxidative phosphoryla-
tion and mitochondrial fatty acid oxidation for their anti-
inflammatory function. Although it is evident that mitochondrial metabo-
lism is regulated during macrophage polarization and essential for
macrophage function, little is known on the regulation and role of peroxi-
somal b-oxidation during macrophage activation. In this study, we show
that peroxisomal b-oxidation is strongly decreased in classically activated
bone-marrow-derived macrophages (BMDM) and mildly induced in alter-
natively activated BMDM. To examine the role of peroxisomal b-oxida-
tion in macrophages, we used Mfp2/ BMDM lacking the key enzyme of
this pathway. Impairment of peroxisomal b-oxidation in Mfp2/ BMDM
did not cause lipid accumulation but rather an altered distribution of
lipid species with very-long-chain fatty acids accumulating in the triglyc-
eride and phospholipid fraction. These lipid alterations in Mfp2/
macrophages led to decreased inflammatory activation of Mfp2/ BMDM
and peritoneal macrophages evidenced by impaired production of several
inflammatory cytokines and chemokines, but did not affect anti-inflam-
matory polarization. The disturbed inflammatory responses of Mfp2/
macrophages did not affect immune cell infiltration, as mice with selective
elimination of MFP2 from myeloid cells showed normal monocyte and
neutrophil influx upon challenge with zymosan. Together, these data
demonstrate that peroxisomal b-oxidation is involved in fine-tuning the
phenotype of macrophages, probably by influencing the dynamic lipid
profile during macrophage polarization.
Keywords: macrophages; metabolism; multifunctional protein 2; peroxiso-
mal b-oxidation.
Abbreviations: ABCD, ATP-binding cassette transporter; ALD, adrenoleucodystrophy; BMDM, bone-marrow-derived macro-
phages; CD, cluster of differentiation; CXCL, chemokine (C–X–C motif) ligand; DMEM, Dulbecco’s modified Eagle’s medium;
FAO, fatty acid oxidation; FBS, fetal bovine serum; GC, gas chromatography; HPLC, high-performance liquid chromatography;
IFN-c, interferon-c; IL, interleukin; LC, liquid chromatography; LPS, lipopolysaccharide; MFP2, multifunctional protein 2; MS,
mass spectrometry; PE, phosphatidylethanolamine; PGC1a, peroxisome proliferator-activated receptor c co-activator 1-a; TAG,
triacylglycerides; TNF, tumour necrosis factor; VLCFA, very-long-chain fatty acids
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Introduction
Macrophages possess a high level of plasticity enabling
them to respond to a variety of triggers such as inflam-
mation, infection or tissue damage.1 Although it is
becoming increasingly recognized that macrophage polar-
ization encompasses a spectrum of activation states,2,3
activated macrophages are often categorized according to
two extremes of the spectrum, namely classically
[lipopolysaccharide/interferon-c (LPS/IFN-c) induced]
and alternatively [interleukin-4 (IL-4)/IL-13-induced]
activated macrophages.1 After classical activation by T
helper type 1-derived IFN-c or Toll-like receptor stimula-
tion, macrophages acquire a pro-inflammatory activation
state and produce inflammatory cytokines, chemokines
and reactive oxygen/nitrogen species. In contrast, T helper
type 2-derived IL-4 induces alternative or anti-inflamma-
tory macrophage activation involved in parasite infections
and wound healing. During polarization, macrophages
adopt a specific gene expression signature that enables
them to execute their highly specialized functions. A cru-
cial aspect of this adaptation is that macrophage skewing
is accompanied by metabolic reprogramming.4 Classical
activation of macrophages induces a metabolic switch to
aerobic glycolysis, similar to the Warburg metabolism
observed in cancer cells.5,6 In contrast, alternative activa-
tion promotes oxidative metabolism, shifting macro-
phages towards oxidative phosphorylation and fatty acid
oxidation (FAO) as main sources of energy production.7
Importantly, the metabolic adaptation is determinant to
acquire a specific phenotype as inhibition of mitochon-
drial FAO prevents the execution/deployment of anti-
inflammatory functions.7
In contrast to the established pivotal role of mitochon-
drial metabolism in macrophage polarization, it is not
known how macrophages rely on other metabolic orga-
nelles, in particular peroxisomes, in different activation
states. Peroxisomes exclusively perform several metabolic
tasks including b-oxidation of very-long-fatty acids
(VLCFA), branched chain fatty acids and some polyunsat-
urated fatty acids.8–10 Key proteins in this pathway are the
ATP-binding cassette transporters 1 to 3 (ABCD1–3)
transporters that transfer substrates across the peroxisomal
membrane and multifunctional protein 2 [multifunctional
protein 2 (MFP2), also known as D-bifunctional protein
and hydroxysteroid 17b-dehydrogenase 4), a central
enzyme that handles most of the substrates.8 Peroxisomal
b-oxidation is indispensable for central nervous system
integrity both during development and later in life.11,12 In
addition, it is currently also hypothesized that peroxisomal
metabolism might influence immunological functions in
myeloid cells. This is mainly based on the therapeutic effi-
cacy of haematopoietic stem cell transplantation in X-
linked adrenoleucodystrophy (ALD), a neurometabolic
disorder caused by mutations in ABCD1 involved in the
import of VLCFA into peroxisomes.13–15 Furthermore,
macrophages of patients with peroxisome biogenesis dis-
orders, MFP2 or ABCD1 deficiency were shown to accu-
mulate characteristic inclusions.16–18 These inclusions are
bi-refringent in polarized light, can be detected with neu-
tral lipid stains and appear as tri-lamellar structures by
ultrastructural analysis. They were found in macrophages
of liver, brain, adrenals and eye and were thought to con-
sist of VLCFA primarily esterified to cholesterol as they
could be dissolved in hexane but not in acetone.19 These
findings suggest that peroxisomal b-oxidation is essential
for macrophage lipid homeostasis. Given the emerging
importance of lipid metabolism for macrophage function,
it seems likely that peroxisomal b-oxidation deficiency can
affect macrophage activation.
To investigate the relationship between peroxisomal b-
oxidation and macrophage function, we first assessed the
expression of peroxisomal b-oxidation enzymes and the
activity of this pathway in macrophages in different acti-
vation states (basal versus LPS/IFN-c versus IL-4). To
evaluate lipid alterations in macrophages lacking peroxi-
somal b-oxidation, lipidomics was applied to control and
Mfp2/ macrophages in non-polarized and polarized
states. Finally, we examined the consequences of peroxi-
somal b-oxidation deficiency on macrophage function by
using in vitro and in vivo approaches. The data indicate a
mutual interaction between peroxisomal b-oxidation and
macrophage polarization.
Materials and methods
Mice
Mfp2/ mice and Mfp2+/+ mice on a Swiss Webster
background20 were used for isolation of bone-marrow-
derived macrophages (BMDM) and peritoneal macro-
phages. Macrophage-specific MFP2 knockout mice
(LysM.Cre*MFP2L/L) were generated by breeding
Mfp2loxP/loxP21 with LysM-Cre22 mice on a C57BL/6J back-
ground. Mice were bred in the animal housing facility of
the KU Leuven, had ad libitum access to water and stan-
dard rodent food, and were kept on a 12 hr : 12 hr
light : dark cycle. All animal experiments were performed
in accordance with the ‘Guidelines for Care and Use of
Experimental Animals’ and fully approved by the
Research Advisory Committee (Research Ethical commit-
tee) of the KU Leuven (#190/2012).
Bone-marrow-derived macrophages
Macrophages were derived from bone marrow precursors
as described by Meerpohl et al.23 Briefly, femurs from
control or Mfp2/ mice were dissected and flushed with
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ice-cold PBS + 10% fetal bovine serum (FBS). Bone mar-
row cells were plated at a density of 9 9 106 cells in a 10-
cm Petri dish (non-tissue-culture-treated, bacterial grade)
in 7 ml Dulbecco’s modified Eagle’s medium with Gluta-
MAX (DMEM) (Thermo Fisher Scientific, Waltham, MA,
USA) supplemented with 20% FBS, 30% L929 condi-
tioned medium and 1% penicillin/streptomycin. After
3 days of culture, 3 ml of medium was added. At day 7,
BMDM were collected by forced pipetting. Thereafter,
cells were plated in DMEM complete medium
(DMEM + 10% FBS + 1% penicillin/streptomycin) and
stimulated for 24 hr with 100 ng/ml LPS + 20 ng/ml
IFN-c for classical activation or 10 ng/ml IL-4 for alterna-
tive activation. CD86 surface expression was measured by
flow cytometry. Briefly, BMDM were incubated for
12 min with CD16/CD32 Fc block (1 : 500; BD Bio-
sciences) and stained with the following conjugated anti-
bodies all from BD Biosciences: CD11b-phycoerythrin-
Cy7 (1 : 400), F4/80-allophycocyanin (1 : 200) and
CD86-fluoroscein isothyocyanate (1 : 500) for 40 min.
Cells were acquired with a FACSCanto (BD Biosciences,
San Diego, CA, USA) and analysed with FLOWJO software
(Treestar, Ashland, OR). To evaluate cytotoxicity, an MTT
assay was performed. After polarization, 3-(4,5-dimethyl-2-
thiazolyl)-2,5,diphenyl-2H-tetrazolium bromide (05 mg/
ml; AppliChem, Darmstadt, Germany) was added to the
cell culture medium and incubated for 4 hr. After the incu-
bation step, 150 ll DMSO was added to the cells and opti-
cal density of dissolved formazan was determined
(570 nm) after subtraction of the background (690 nm).
Peritoneal macrophages
Peritoneal macrophages were isolated from both control
and Mfp2/ mice as described by Ray and Dittel.24 Mice
were anaesthetized and injected intraperitoneally with 5 ml
ice-cold RPMI-1640 + 10% FBS. The peritoneal exudate
was collected after softly rubbing the abdomen for 5 min
and plated in 24-well plates at 5 9 105 cells/well in RPMI
complete medium (RPMI + 10% FBS + 1% penicillin/
streptomycin). After 4 hr, cells were washed twice with
PBS (37°) to remove contaminating cells and stimulated
for 24 hr with 100 ng/ml LPS + 20 ng/ml IFN-c for classi-
cal activation or 10 ng/ml IL-4 for alternative activation.
RNA isolation and real-time PCR
RNA isolation was performed by Trizol extraction for
both macrophages and tissue samples according to the
manufacturer’s protocol (ThermoFisher Scientific, Wal-
tham, MA, USA). Two microgrammes of total RNA was
retro-transcribed into cDNA by qScript cDNA SuperMix
(Quanta Biosciences, Gaithersburg, MD, USA) according
to the manufacturer’s instructions. Quantitative real-time
transcription PCR was performed on samples in triplicate
with the LightCycler 480 SYBR Green I Master (Roche
Applied Science, Basel, Switzerland) using the Light Cycler
480 (Roche, Vilvoorde, Belgium). Results were quantified
using the 2DDCT method.25 The expression levels of the
genes of interest were normalized to the expression levels
of the reference gene Rpl32. Primer sequences used are
listed in the Supplementary material (Table S1).
Cytokine measurements
Cytokine levels of tumour necrosis factor-a (TNF-a), IL-6
and CXCL1 were quantified by cytometric bead array
(BD Bioscience). Samples were acquired on FACSCanto
flow cytometer (BD Bioscience) and analysed by FCAP v3.0
analysis software (Soft Flow, Inc., Pecs, Hungary).
Inflammasome activation
Inflammasome activity was determined by measuring the
production of IL-1b (as described above) after priming
the BMDM for 4 hr with LPS (500 ng/ml) followed by
45 min treatment with ATP (25 mM or 5 mM) (Thermo-
Fisher Scientific).
Quantification of peroxisomes and lipid droplets
The BMDM were seeded in 24-well plates at density of
100 000 cells/well and exposed to LPS/IFN-c or IL-4 as
described above. After the stimulation, cells were fixed for
20 min in 4% formaldehyde and washed with PBS. For
peroxisome staining, cells were permeabilized with 1%
Triton X-100 and blocking was performed with 5% bovine
serum albumin. Thereafter, cells were incubated for 1 hr
with anti-peroxisomal membrane protein 70 antibody
(1 : 500; Sigma-Aldrich, St Louis, MO, USA), followed by
1 hr incubation with Alexa-488-conjugated secondary
antibody (1 : 1000; Molecular Probes, Eugene, OR, USA).
For staining of lipid droplets, cells were incubated for 1 hr
with boron-dipyrromethene 493/503 (1 lg/ml; Sigma-
Aldrich) and washed with PBS. All images were acquired
with an inverted IX-81 microscope connected to a CCD-
FV2T digital camera (Olympus, Aartselaar, Belgium) and
processed with LSM IMAGE browser software (Zeiss, Ober-
kochen, Germany). For each mouse 20 cells were imaged
and further, during statistical analysis, considered as inde-
pendent samples. The number of peroxisomes as well as
the number and size of lipid droplets were determined
using IMAGEJ Software (NIH, Rockvill, MD, USA).
Immunohistochemistry
Mice were transcardially perfused with PBS and 4%
formaldehyde and processed for cryosections. Brain sec-
tions were incubated with rabbit anti-mouse Iba1
(1 : 500; Wako, Richmond, VA, USA) and liver and
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spleen sections with rat anti-mouse F4/80 (1 : 500;
BioRad, Hercules, CA, USA). Horseradish peroxidase-
labelled secondary antibodies (1 : 200) were applied for
1 hr and fluorescently labelled with a cyanine 2 (FITC)
TSA kit (Perkin Elmer, Wahtham, MA, USA). Images
were acquired with an Olympus BX41 light microscope
equipped with CELLF software (Olympus).
Lipid analysis
The BMDM of Mfp2+/+ and Mfp2/ mice were seeded
in 10-cm tissue-culture dishes at a density of 4 million
cells/dish and exposed to LPS/IFN-c or IL-4 as described
above. Cells were collected by scraping and cell pellets
were kept at 80° until further analysis.
Total triacylglycerides (TAG) were determined on lipid
extracts with a peroxidase-coupled enzymatic assay26 and
normalized to protein.27
Total fatty acids were quantified by gas chromatography
mass spectrometry (GC-MS) in negative chemical ioniza-
tion mode as described by Baarine et al.28 Cell pellets, sus-
pended in 100 ll of saline, were spiked with a mix of
deuterated fatty acids [myristic acid-d3 (14:0-d3), palmitic
acid-d3 (16:0-d3), stearic acid-d3 (18:0-d3), linoleic acid-
d3 (18:2-d3), arachidic acid-d3 (20:0-d3), arachidonic
acid-d8 (20:4-d8), behenic acid-d3 (22:0-d3), lignoceric
acid-d4 (24:0-d3) and cerotic acid-d4 (26:0-d4)], followed
by lipid extraction, and alkaline hydrolysis. Fatty acids were
derivatized to pentafluorobenzyl esters. Each fatty acid
concentration was determined by the relative area ratio
method using the closest deuterated internal standard.
For determining the composition of TAG and phospho-
lipids total lipids were extracted from cells by the Folch
procedure29 and analysed by a Dionex Ultimate 3000
HPLC coupled on-line to a hybrid quadrupole-orbitrap
mass spectrometer Q-Exactive (ThermoFisher Scientific).
The liquid chromatography (LC)/ESI-MS analysis of TAG
was performed using a C18 reverse phase column (Luna,
3 lm, 100 A, 150 9 2 mm; Phenomenex, Torrance, CA,
USA) and gradient solvents as previously described.30 MS
spectra were acquired in positive ion mode, using range
zoom (500–1000 m/z). TAG cations were formed through
molecular ammonium adduction (TAG + NH4). Phos-
pholipids (PL) were analysed using a silica column (Luna
3 lm, 100 A, 150 9 2 mm; Phenomenex) as previously
described.31 The spectra of PL were acquired in negative
ion mode, using range zoom (400–1600 m/z). All scans
were acquired in data-dependent mode with isolation
width of 10 Da. Analysis of LC/MS data was performed
using software package SIEVETM (ThermoFisher Scientific).
Metabolic assays
To evaluate fatty acid b-oxidation of mitochondrial and
peroxisomal substrates during macrophage polarization,
BMDM were seeded in T25-flasks and exposed to LPS/
IFN-c or IL-4 as described above. Subsequently, cultures
were incubated with 5 lM 1–14C-labelled fatty acid,
bound to defatted albumin as described before32 for
20 hr, followed by collection of 14CO2. The medium was
analysed for acid-soluble oxidation products, and the
adherent cells were collected in lysis medium (5 mM 3-
(N-morpholino)propanesulphonic acid pH 72 – 1 mM
EDTA – 01% SDS). Aliquots of the lysates were analysed
for protein and subjected to lipid extraction. The extracts
were analysed for phospholipid content33 and separated
by thin-layer chromatography to determine the incorpo-
ration of label in lipids.
To evaluate glycolysis and mitochondrial fatty acid b-
oxidation in Mfp2/ compared with control BMDM in
basal and activated state, BMDM were seeded in 48-well
plates at a density of 150 000 cells/well and exposed to
LPS/IFN-c as described above. FAO and glycolysis were
measured on the basis of 3H2O production as described
previously.34 Briefly, cells were incubated with DMEM
complete medium containing 2 lCi/ml [9,10-3H]palmi-
tate (for FAO) or 2 lCi/ml [5-3H]-D-glucose (for glycol-
ysis) (Perkin Elmer). After 2 hr of incubation, cell
supernatant was transferred into glass vials. The glass
vials were sealed with rubber stoppers containing hanging
wells with H2O-soaked Whatman paper. After saturation
was reached (48 hr at 37°), the radioactivity was deter-
mined by liquid scintillation counting. All the measure-
ments were made in triplicate and were normalized to
total protein content. For the determination of protein
content, after the supernatant was collected, the cells
where lysed in 30 ll radioimmunoprecipitation assay
buffer (25 mM Tris–HCl pH 76 – 150 mM NaCl – 1%
nonidet P-40 – 1% sodium deoxycholate – 01% SDS) of
which 5 ll was used for the assay. Total protein content
was determined using a PierceTM BCA Protein Assay Kit
(Thermo Scientific) following manufacturer’s instruc-
tions.
Zymosan-induced peritonitis
Peritonitis was induced in 6- to 8-week-old male and
female LysM.Cre*MFP2L/L and MFP2L/L mice by injecting
1 ml of 1 mg/ml zymosan (Sigma-Aldrich) intraperi-
toneally.35 Mice were killed and peritoneal exudate was
harvested 6 hr post-injection. Then, 2 9 105 cells were
used for FACS analysis. First, cells were incubated for
12 min with CD16/CD32 Fc block (1 : 500; BD Bio-
sciences). Cells were stained with the following conjugated
antibodies all from BD Biosciences: CD45.2-fluoroscein
isothyocyanate (1 : 400), CD11b- phycoerythrin-Cy7
(1 : 400), Ly6C-phycoerythrin (1 : 500) and Ly6G-allo-
phycocyanin (1 : 200) for 40 min. Cells were acquired with
a FACSCanto (BD Biosciences) and analysed with FLOWJO
software (Treestar).
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Statistical analysis
For statistical analysis GRAPHPAD PRISM software (version
5.0 and 6.0; GraphPad Software, Inc., San Diego, CA,
USA) was used and the following tests were performed:
unpaired two-sided Student’s t-test, one-way analysis of
variance repeated measures or two-way analysis of vari-
ance multiple comparison followed by Tukey post-test.
Data are shown as mean  SEM and statistical signifi-
cance was set at P ˂ 005.
Results
Peroxisomal b-oxidation is strongly reduced in
classically activated macrophages
To investigate the regulation of peroxisomal FAO during
macrophage polarization, we first measured the relative
expression of genes related to peroxisomal b-oxidation in
both classically (LPS/IFN-c) and alternatively (IL-4) acti-
vated macrophages. Expression of acyl-CoA oxidase 1
(Acox1), multifunctional protein-2 (Hsd17b4) and enoyl-
CoA, hydratase/3-hydroxyacyl CoA dehydrogenase
(Ehhadh), encoding multifunctional protein 1, were
strongly reduced after induction with LPS/IFN-c
(Fig. 1a–c). In IL-4-induced macrophages, only Acox1
gene expression was significantly increased compared
with macrophages in basal condition whereas no differ-
ences in gene expression of peroxisomal Ehhadh and
Hsd17b4 were observed (Fig. 1a–c). We also assessed the
expression of the mitochondrial b-oxidation enzyme
medium-chain acyl-CoA dehydrogenase (Acadm) and
found that it was strongly reduced in classically activated
macrophages, confirming previous reports5 (Fig. 1d). To
assess whether the transcript changes had a functional
impact, we measured mitochondrial and peroxisomal
fatty acid oxidation in resting and activated macro-
phages. Classical activation of macrophages with LPS/
IFN-c reduced both mitochondrial b-oxidation of palmi-
tate (C16:0) and peroxisomal fatty acid b-oxidation of
lignoceric acid (C24:0) and 2-methylhexadecanoic acid
(2-Me-C16:0) by ~ 50–60% (Fig. 1e). After alternative
activation with IL-4, we did not find changes in mito-
chondrial b-oxidation in line with unaltered Acadm
expression (Fig. 1e). In contrast, peroxisomal b-oxidation
(2-Me-C16:0 and C24:0) was clearly induced during
alternative activation, which was most pronounced for 2-
Me-C16:0 (Fig. 1e). To test whether other peroxisomal
metabolic pathways were deregulated in polarized macro-
phages, we measured peroxisomal a-oxidation activity by
using 3-Me-C16:0, a substrate for a-oxidation, but no
adaptations were seen. Next, to examine whether the
observed changes in peroxisomal metabolic activity were
due to altered abundance of peroxisomes, we counted
peroxisome numbers in polarized macrophages. Even
though we found decreased peroxisomal b-oxidation
during LPS/IFN-c stimulation, the number of peroxi-
somes was up-regulated by ~65% (Fig. 1f). Together,
these data clearly show that classical macrophage polar-
ization induces dynamic changes in peroxisomal FAO
similar to mitochondrial FAO.
Lipid changes in polarized control and MFP2-
deficient murine macrophages
As indicated above, we show that peroxisomal b-oxida-
tion is dynamically regulated during macrophage polar-
ization, similar to mitochondrial b-oxidation. It has been
reported that macrophage activation induces pronounced
changes in lipid metabolism including increased triacyl-
glyceride storage and lipid droplet accumulation.36 More-
over, blocking mitochondrial FAO significantly affects the
polarization of macrophages.7 It is however unknown
whether peroxisomal b-oxidation activity plays a modula-
tory role in activated macrophages. Given the pro-
nounced decrease in peroxisomal b-oxidation in
classically activated macrophages, we investigated whether
peroxisomal b-oxidation deficiency affects macrophage
activation. To this end, we characterized the metabolic
and inflammatory response of classically activated
BMDM lacking MFP2, a central enzyme of the peroxiso-
mal b-oxidation pathway (Mfp2/). First, we confirmed
that the oxidation of C24:0 and 2M-C16:0 was reduced
in Mfp2/ BMDM (see Supplementary material,
Fig. S1a). As expected mitochondrial b-oxidation and
peroxisomal a-oxidation were unaffected (see Supplemen-
tary material, Fig. S1b,c). Next, we investigated the
impact of deficient peroxisomal b-oxidation on the lipid
profile of BMDM derived from control and Mfp2/
mice. In line with previous reports, we confirmed that
classical macrophage activation had a pronounced effect
on lipid droplet dynamics. Although lipid droplet num-
ber was mildly reduced after LPS/IFN-c treatment, the
size of lipid droplets was significantly increased in classi-
cally activated macrophages (Fig. 2b). Both lipid droplet
number and lipid droplet size were unaltered in alterna-
tively activated macrophages compared with the basal
state. In Mfp2/ macrophages, similar changes were
observed but no differences were detected between con-
trol and Mfp2/ macrophages with regard to lipid dro-
plet content both in non-polarized and polarized
conditions. The only exception was a slight increase of
lipid droplet number in alternatively activated Mfp2/
macrophages compared with controls. Similarly, quantifi-
cation of triglyceride content showed a tendency for
increased neutral lipid storage in classically activated
macrophages of both genotypes versus the respective con-
trols, but no differences between control and Mfp2/
macrophages were observed (Fig. 2c). Because we did not
detect differences in general lipid droplet content between
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control and Mfp2/ macrophages, we next performed
general and detailed lipidomic analysis using GC-MS-
NCI and LC-MS/MS to obtain better insight into the
fatty acid profile, as well as TAG and PL composition of
control and Mfp2/ BMDM mainly focusing on peroxi-
somal b-oxidation substrates (data summarized in the
Supplementary material, Table S2–S4). We observed that
peroxisomal b-oxidation-deficient BMDM show pro-
nounced accumulation of VLCFA, including C24:0,
C24:1, C26:0 and C26:1 in basal, LPS/IFN-c polarized
and IL-4 polarized states, whereas these fatty acids were
present at extremely low levels in control BMDM
(Fig. 3a–d). On the other hand, no differences were
observed in saturated long-chain fatty acids between con-
trol and Mfp2/ macrophages, which is in line with the
unaltered mitochondrial b-oxidation (C16:0 oxidation) in
Mfp2/ macrophages (Fig. 3e and see Supplementary
material, Table S2). We also observed accumulation of
several polyunsaturated fatty acids including c-linoleic
acid (C18:3 n-6), mead acid (C20:3 n-9) and eicosapen-
taenoic acid (20:5 n-3) in Mfp2/ macrophages (Fig. 3f–
h). In contrast, arachidonic acid (C20:4 n-6) and docosa-
hexaenoic acid (C22:6 n-3), which are known as fatty
acids with pro- and anti-inflammatory functions, respec-
tively, showed no changes between activation states or
BMDM phenotype (Fig. 2i,j). Furthermore, we checked
whether stored TAG contained higher levels of VLCFA.
Detailed lipidomic analysis showed that peroxisomal b-
oxidation deficiency resulted in increased levels of TAG
species containing a single saturated or mono-unsatu-
rated fatty acid with chain lengths ≥ C24 (26–31 fold
compared with control) (Fig. 4a,b). Notably, these TAG
species also accumulated when control macrophages were
converted from the basal to LPS/IFN-c polarized pheno-
type, in accordance with the suppressed peroxisomal b-
oxidation activity. It was also remarkable that TAG spe-
cies containing VLCFA at two or all three positions (e.g.
68:4 and 70:4) were detectable in Mfp2/ but not in
control macrophages, albeit at extremely low levels (see
Supplementary material, Table S3). We further examined
whether the fatty acid profile in phospholipids was
altered as a consequence of peroxisomal b-oxidation defi-
ciency by analysing phosphatidylethanolamine (PE) spe-
cies (see Supplementary material, Table S4 and selected
species shown in Fig. 4c). We found that minor PE spe-
cies containing VLCFA showed dynamic changes during
macrophage polarization, as evidenced by a two- to
threefold increase after stimulation with LPS/IFN-c.
Although similar polarization-dependent dynamics were
seen in Mfp2/ macrophages, these species were strongly
enriched in all states (three- to tenfold) compared with
control (Fig. 4c). Taken together, we show that macro-
phage polarization with LPS/IFN-c induces dynamic
changes in TAG and PE lipid species containing peroxi-
somal b-oxidation substrates. In addition, an increased
accumulation of VLCFA is observed in Mfp2/ macro-
phages in all activation states, but always in very low
levels compared to the total lipid fraction.
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Figure 1. Both peroxisomal and mitochondrial
b-oxidation are strongly reduced in classically
activated macrophages. (a–d) Gene expression
of peroxisomal acyl-CoA oxidase 1 (Acox1) (a),
multifunctional protein-2 (Hsd17b4) (b) and
enoyl-CoA, hydratase/3-hydroxyacyl CoA dehy-
drogenase (Ehhadh) (c) and mitochondrial
medium chain acyl-CoA dehydrogenase
(Acadm) (d) in classically (LPS/IFN-c) and
alternatively (IL-4) activated bone-marrow-
derived macrophages (BMDM) compared with
basal conditions (n = 4 versus 4 versus 4); (e)
Degradation of substrates by peroxisomal
b-oxidation (2-Me-C16:0 and C24:0), mito-
chondrial b-oxidation (C16:0) and peroxisomal
a-oxidation (3Me C16:0) in classically and
alternatively activated BMDM (n = 4 versus 4
versus 4) expressed as percentage of CO2
release in basal conditions; (f) Number of per-
oxisomes per cell in classically and alternatively
activated BMDM compared with basal condi-
tions (n > 15). Bars represent mean  SEM.
Statistical differences based on one-way analy-
sis of variance test: *P < 005, **P < 001,
***P < 0001.
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MFP2-deficient BMDM have reduced inflammatory
cytokine production during classical activation
It has been proposed that accumulation of VLCFA might
enhance inflammatory signalling in diverse cell types.37–40
To investigate whether the accumulation of VLCFA in
different lipid species affects classical and alternative
polarization in BMDM Mfp2/ macrophages, we first
measured gene expression of a panel of inflammatory
genes, including cytokines (Tnf, Il1b, Il1a, Il6, Il12a,
Il12b) and chemokines (Cxcl1, Cxcl2, Ccl3, Ccl5, Ccl8)
after classical activation with LPS/IFN-c. The gene expres-
sion of inflammatory cytokines and chemokines as well as
their production, was low or below the detection limit in
basal state both in control and Mfp2/ macrophages
(Fig. 5a,b). Unexpectedly, after activation with LPS/IFN-
c, Mfp2/ macrophages showed blunted inflammatory
responses as the transcript expression of Il6, Il1a, Il12a,
Il12b, Cxcl1, Cxcl2 and Ccl3 was significantly lower
compared with control macrophages (Fig. 5a,b). Next, we
measured cytokine secretion by Mfp2/ macrophages. In
the basal state all cytokines and chemokines measured
were undetectable in the medium of both control and
Mfp2/ macrophages (data not shown). After stimula-
tion with LPS/IFN-c, Mfp2/ macrophages produced
lower levels of IL-6 and CXCL1 compared with control
macrophages in line with the transcript data (Fig. 5c).
Moreover, although we could not detect differences in
gene expression of Tnfa, TNF-a production was signifi-
cantly reduced in Mfp2/ macrophages compared with
control macrophages (Fig. 5c). To evaluate possible
effects of peroxisomal b-oxidation deficiency on inflam-
masome activation, IL-1b production was measured after
stimulation with LPS and ATP. Control and Mfp2/
macrophages showed similar production of IL-1b after
the challenge, indicating that peroxisomal b-oxidation
deficiency does not affect inflammasome activation (see
Supplementary material, Fig. S2). To exclude that the
50
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blunted inflammatory response of Mfp2/ macrophages
was due to reduced cell survival upon stimulation, we
performed an MTT-viability assay. But did not observe a
reduction in cell survival of Mfp2/ compared with con-
trol macrophages upon LPS/IFN-c treatment (see Supple-
mentary material, Fig. S3). To investigate whether
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reduced cytokine and chemokine production by classically
activated Mfp2/ macrophages was due to defective
polarization, we evaluated the expression of CD86, a co-
stimulatory molecule that is strongly expressed by classi-
cally activated macrophages, by flow cytometry. Although
macrophage activation induced CD86 expression on
CD11b+ F480+ BMDM, no differences were detected
between control and Mfp2/ macrophages in basal state
and during classical activation indicating adequate polar-
ization of Mfp2/ macrophages (Fig. 5d).
Together, these data show that MFP2 deficiency has
subtle dampening effects on the classical activation of
macrophages, mainly influencing cytokine production. To
determine whether Mfp2/ macrophages also respond
differently during alternative polarization, we measured
the gene expression of typical anti-inflammatory markers
in control and Mfp2/ BMDM. Stimulation with IL-4
robustly induced gene expression of anti-inflammatory
genes such as Arg1, Mrc1, Retnla, Ym1 and Vegf in both
control and Mfp2/ BMDM but no differences were
observed between the two genotypes with the exception
of Ym1, which was slightly more induced in Mfp2/
macrophages upon IL-4 stimulation (Fig. 6).
MFP2-deficiency does not influence metabolic
adaptation during macrophage activation
Recent evidence indicates that metabolic adaptation is an
important determinant of the functional phenotype
acquired by macrophages. During inflammatory condi-
tions (e.g. activation with LPS and/or IFN-c), macro-
phages display a metabolic shift towards the anaerobic
glycolytic pathway whereas FAO is down-regulated.
Although this metabolic adaptation is probably necessary
to meet the rapid energy requirement of classically acti-
vated macrophages, it has been shown that disturbances
in metabolic energy expenditure strongly influence the
functional phenotype of macrophages.7,41 To investigate
whether the reduced inflammatory activation of Mfp2/
macrophages is due to an imbalance in this metabolic
adaptation, we measured glycolysis and C16:0 FAO in
basal and LPS/IFN-c conditions. Although we could con-
firm that the switch from basal to classically activated
macrophages was associated with increased glycolysis and
decreased C16:0 FAO, we did not detect any differences
between control and Mfp2/ macrophages, indicating
that the blunted inflammatory response during classical
activation is not due to a defect in metabolic adaptation
(Fig. 7).
Macrophage-specific deletion of MFP2 does not affect
immune cell influx in zymosan-induced peritonitis
As a next step, we wanted to evaluate the functional rele-
vance of the decreased inflammatory activation of MFP2-
deficient macrophages in vivo. To this end, we generated
mice with myeloid-cell-specific deletion of MFP2 by
crossing LysM.Cre mice with Mfp2LoxP/LoxP mice (LysM-
Mfp2/). These mice developed normally and showed
no overt phenotype. Gene expression analysis and
immunohistochemistry showed normal expression of
inflammatory markers (Tnf, Il6 and Cxcl1) and normal
macrophage morphology/abundance in spleen, liver and
brain under basal conditions (see Supplementary material,
Fig. S4). In addition, flow cytometric analysis of the peri-
toneal exudate showed normal abundance of CD11b+/F4/
80+ peritoneal macrophages in LysM-Mfp2/ compared
with Mfp2L/L mice (Fig. 8a). To characterize the classical
activation of MFP2-deficient macrophages in vivo, LysM-
Mfp2/ mice were subjected to zymosan-induced peri-
tonitis. In this model, Toll-like receptor 2 activation by
zymosan activates resident peritoneal macrophages that in
turn produce chemokines to attract other innate effector
cells (mainly neutrophils and monocytes) to the peri-
toneal cavity. In the acute phase of the induced peritoni-
tis (i.e. 6 hr post-injection), we observed no differences
in number of monocytes (Ly6Chi, Ly6Gneg) and neu-
trophils (Ly6Cmid/low, Ly6Gpos) in peritoneal exudate
between control and LysM-Mfp2/ mice suggesting that
MFP2-deficiency does not affect acute activation of resi-
dent macrophages in vivo (Fig. 8b–d). To remove doubt
of possible differences between in vitro and in vivo data
due to different responses of Mfp2/ peritoneal macro-
phages compared with Mfp2/ BMDM upon LPS/IFN-c
stimulation, we evaluated the response of Mfp2/ peri-
toneal macrophages to classical activation. Gene expres-
sion analysis of inflammatory cytokines and chemokines
confirmed the blunted activation of peritoneal Mfp2/
macrophages upon stimulation with LPS/IFN-c compared
with controls (Fig. 9a). Upon IL-4 stimulation, there were
no changes in gene expression of anti-inflammatory
markers between Mfp2/ and control peritoneal macro-
phages with the exception of Retnla as observed in
BMDM (Fig. 9b). Altogether, these data indicate that
even though Mfp2/ macrophages show decreased pro-
duction of inflammatory chemokines in vitro, they are
able to mount a normal immune response after an acute
inflammatory trigger in vivo.
Discussion
In this study we report that, similar to mitochondrial
fatty acid oxidation, peroxisomal fatty acid oxidation is
strongly impaired during classical macrophage activation
and mildly induced during alternative activation. The
suppression of peroxisomal b-oxidation in classical
macrophages leads to increased incorporation of peroxi-
somal substrates in triacylglycerides and phospholipids.
We further demonstrated that BMDM lacking peroxiso-
mal b-oxidation (Mfp2/ macrophages) showed a mildly
ª 2017 John Wiley & Sons Ltd, Immunology, 153, 342–356350
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reduced inflammatory response upon stimulation with
LPS/IFN-c in vitro, but mice lacking peroxisomal b-oxi-
dation in the myeloid cell compartment mounted a nor-
mal immune response in the peritoneal cavity. Our data
shed new light on the dynamic regulation of lipid meta-
bolic pathways during macrophage polarization and pro-
vide unanticipated evidence that peroxisomal b-oxidation
deficiency does not lead to increased inflammatory activa-
tion of macrophages.
Recent advances in immunometabolism underscore the
essential role of lipid metabolism in regulating macro-
phage function and phenotype. Depending on the activa-
tion state, macrophages employ different metabolic
pathways to meet their energy requirements. Metabolic
adaptation of polarized macrophages is not only required
for proper energy expenditure, but also drives specific
effector functions in macrophages.42,43 It has indeed been
shown that a shift toward glycolysis and fatty acid synthe-
sis, and away from Krebs cycle and FAO, skews macro-
phages into a pro-inflammatory state.44–46 This metabolic
shift, which can be induced by Toll-like receptor agonists
such as LPS, seems to be essential for their functional
phenotype as inhibition of glycolysis reduces the produc-
tion of certain pro-inflammatory cytokines by classically
activated macrophages.41 Alternatively activated macro-
phages on the other hand rely completely on fatty acid
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Figure 5. Reduced inflammatory response of Mfp2/ bone-marrow-derived macrophages (BMDM). (a, b) Gene expression of pro-inflammatory
cytokines (a) and chemokines (b) in basal and classically activated Mfp2/ BMDM compared with control BMDM (n = 5–8 versus 5–8); (c)
Secretion of pro-inflammatory cytokines and chemokines in classically activated Mfp2/ BMDM compared with control BMDM (n = 6 versus
6); (d) Expression of CD86 marker does not differ in classically activated Mfp2/ BMDM compared with control BMDM (n = 3 versus 3). Bars
represent mean  SEM. Statistical differences based on t-test or two-way analysis of variance test: ns P > 005, *P < 005, **P < 001.
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oxidation and oxidative metabolism to meet their energy
demand, and inhibition of mitochondrial FAO affects
alternative polarization.7,47 The reprogramming to oxida-
tive metabolism was shown to be mediated by peroxi-
some proliferator-activated receptor c co-activator 1-b
(PGC1b).7 In contrast, little attention has been paid to
the molecular determinants driving the strong suppres-
sion of mitochondrial b-oxidation in classically activated
macrophages. Our findings that this is accompanied by
profoundly reduced expression of key enzymes of peroxi-
somal b-oxidation, leading to reduced activity of this
pathway, indicate that common transcriptional regulators
of both mitochondrial and peroxisomal fatty acid oxida-
tion are involved. Potential candidates are the nuclear
receptors, peroxisome proliferator-activated receptors,
oestrogen-related receptors and hepatocyte nuclear factor
4 that are known to regulate mitochondrial fatty acid cat-
abolism in concert with the PGC1 co-activators. To date,
for peroxisomal b-oxidation only peroxisome prolifera-
tor-activated receptor-a48 and PGC1a49 were shown to
control expression of the enzymes but it cannot be
excluded that additional factors are involved. The activity
of these transcriptional regulators not only depends on
their expression levels but also on ligand concentration
and post-translational modifications, calling for an exten-
sive investigation of the underlying mechanisms.
Another remarkable finding of this study is the blunted
inflammatory response of Mfp2/ macrophages. This is
surprising given the accumulation of VLCFA in Mfp2/
macrophages, which further increased upon stimulation
with LPS/IFN-c, together with the proposed role of
VLCFA as a potential trigger of inflammatory activation.
It has indeed been suggested that VLCFA accumulation, a
typical hallmark of peroxisomal b-oxidation disorders
such as X-linked ALD, might trigger an inflammatory
cascade in immune cells that can subsequently lead to the
neuroinflammatory disease seen in disorders such as cere-
bellar ALD. Several studies have indeed reported that
abnormal VLCFA accumulation could increase inflamma-
tory activation of murine astrocytes, peritoneal macro-
phages, human fibroblasts and mononuclear cells.37–40 In
murine astrocytes, silencing of Abcd1 and Abcd2, two per-
oxisomal transporters involved in shuttling substrates into
peroxisomes, leads to a threefold increase of C26:0
together with activation of nuclear factor-jB, activator
protein-1 and CCAAT-enhancer-binding protein and
increased production of inflammatory cytokines such as
TNF-a and IL-1b.38,50,51 Treatment of Abcd1/2 silenced
astrocytes with a mixture of oleic acid/erucic acid (Loren-
zo’s Oil) not only normalizes VLCFA levels but also sig-
nificantly reduces the production of inflammatory
cytokines, suggesting that VLCFA accumulation is indeed
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underlying the inflammatory activation of peroxisomal b-
oxidation deficient astrocytes. Also in Abcd1/ peritoneal
macrophages, accumulation of VLCFA coincides with
enhanced production of inflammatory cytokines such as
TNF-a, IL-6 and IL-12p70.37 In this study, we wanted to
further validate these observations by investigating the
inflammatory activation of bone-marrow-derived and
peritoneal macrophages lacking the central enzyme of
peroxisomal b-oxidation, MFP2. Although we observed a
pronounced accumulation of different VLCFA in both
the neutral lipid and PE fraction, Mfp2/ macrophages
show a decreased rather than increased inflammatory
activation upon stimulation with LPS/IFN-c. In addition,
our in vivo studies also provide new insight that macro-
phages lacking peroxisomal b-oxidation are able to
mount a normal immune response upon stimulation, as
myeloid-cell-specific MFP2 knockout mice attract similar
amounts of monocytes and neutrophils upon classical
activation. These findings do not support the paradigm
that VLCFA accumulation potentiate inflammatory acti-
vation of macrophages, thereby initiating an inflamma-
tory cascade. Our data nevertheless indicate that
peroxisomal b-oxidation deficiency can affect macrophage
homeostasis and macrophages can serve as relevant cellu-
lar tools to study altered innate immune cell function in
peroxisomal b-oxidation deficiencies. This is particularly
relevant given the proposed role of macrophages as
pathogenic drivers of the neuroinflammatory cascade in
cerebellar ALD. Of interest, a recent study provided new
evidence that mainly monocytes of ALD patients are
metabolically affected whereas lymphocytes are not.52 In
this respect, it is interesting to further follow up on how
peroxisomal b-oxidation could affect different signalling
pathways involved in macrophage homeostasis. Recent
integrated genomics, metabolomics and lipidomics studies
on mononuclear cells isolated from ALD patients indeed
identified novel pathway alterations, including insulin sig-
nalling, glycerophospholipid metabolism and bile acid
metabolism.53,54 It was recently shown that induced
pluripotent stem cells derived from ALD patients strongly
induce Ch25h, the gene encoding cholesterol 25-hydroxy-
lase.55 Importantly, it was shown that 25-hydroxycholes-
terol, but not VLCFA, acts as an endogenous regulator of
NLRP3-induced inflammasome activation in BMDM,
possibly underlying the neuroinflammatory cascade asso-
ciated with cerebellar ALD. In line with this study, we did
not find potentiation of inflammasome activation in
Mfp2/ macrophages, supporting the idea that the
observed alterations in Abcd1-deficient macrophages are
not merely due to VLCFA accumulation. These results
MFP2L/L
MFP2L/L
100
80
60
40
20
Monocytes Neutrophils Monocytes Neutrophils
5·0 × 106
4·0 × 106
3·0 × 106
2·0 × 106
1·0 × 106
0
%
 o
f C
D1
1b
 +
 m
ye
lo
id
 c
el
ls
Ab
so
lu
te
 n
um
be
r/e
xu
da
te
0
30·2 ± 4·5
(a)
(c) (d)
(b)
CD
11
b
F4/80 Ly6G
Ly
6C
29·9 ± 4·3
LysM.Cre * MFP2L/L
LysM.Cre * MFP2L/L
LysM.Cre * MFP2L/LMFP2L/L
Figure 8. Reduced pro-inflammatory response of Mfp2/ macrophages does not affect their function in vivo. (a) Percentage of macrophages
defined as CD11b+/F480+ cells in peritoneal exudate of LysM.Cre*Mfp2L/L mice compared with Mfp2L/L mice (n = 4 versus 4); (b–d) Number of
monocytes and neutrophils in peritoneal exudate after zymosan treatment expressed as % of CD11b+ myeloid cells (c) or as absolute cell number
(d) in LysM.Cre*Mfp2L/L mice compared with Mfp2L/L mice (n = 4 versus 6). Bars represent mean  SEM.
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nevertheless underscore the importance of identifying
novel mediators associated with disturbed immune cell
function in peroxisomal b-oxidation deficiency. In view
of the fact that the brain is the prime site where inflam-
mation develops in peroxisomal b-oxidation deficiency, it
will be of interest to also assess the inflammatory reactiv-
ity of microglia specifically lacking peroxisomal b-oxida-
tion enzymes. Although these resident macrophages of
the brain bear many similarities with peripheral mono-
cytes/macrophages they also display distinct characteris-
tics.
Taken together, we provide novel insights on the regu-
lation of peroxisomal b-oxidation during macrophage
polarization and provide unanticipated novel information
on the impact of peroxisomal b-oxidation deficiency on
inflammatory activation of macrophages.
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Figure 9. Reduced pro-inflammatory and unaltered anti-inflammatory response of Mfp2/ peritoneal macrophages. (a, b) Gene expression of
pro-inflammatory (a) and anti-inflammatory (b) markers in classically and alternatively activated Mfp2/ compared with control peritoneal
macrophages (n = 6 versus 6). Bars represent mean  SEM. Statistical differences based on t-test: ns P > 005, *P < 005, **P < 001,
***P < 0001, ****P < 00001.
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Note
1 The gene encoding multifunctional protein 2 (MFP2) is
Hsd17b4, a name related to the initial description of this
enzyme as a steroid dehydrogenase. In this text, the
knockout will be referred to as Mfp2/.
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